Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case–control study

Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case–control study

Bibliographic Details
Main Authors:	Zhang, Puhong, Gao, Jialin, Pu, Chun, Feng, Gang, Wang, Lizhuo, Huang, Lizhu, Tao, Qingsong, Zhang, Yao
Format:	Online
Language:	English
Published:	BioMed Central 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025546/

Similar Items

A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus
by: ZHANG, Pu-Hong, et al.
Published: (2016)

Peculiarities of hyperlipidaemia in tumour patients.
by: Dilman, V. M., et al.
Published: (1981)

NON-PHARMACOLOGICAL THERAPY OF HYPERLIPIDAEMIA
by: Urgra Narayan Pathak, et al.
Published: (2003-01-01)

Lessons from treatment resistant hyperlipidaemia
by: Parsons, Elizabeth, et al.
Published: (2016)

Apolipoprotein M
by: Luo, Guanghua, et al.
Published: (2004)

Religious fasting: an alternative approach to improve hyperlipidaemia
by: Khattak, Muhammad Muzaffar Ali Khan, et al.
Published: (2012)

Fixed drug combination in hypertension and hyperlipidaemia in the developing world
by: Seedat, YK
Published: (2008)

Religious fasting: an alternative approach to improve hyperlipidaemia
by: Muhammad, Muzaffar Ali Khan Khattak, et al.
Published: (2012)

Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus
by: Davey, Rachel A, et al.
Published: (2006)

Association of immune recovery with hyperlipidaemia and apolipoprotein gene polymorphisms following highly active antiretroviral therapy in a cohort of Chinese HIV patients
by: Chan, Denise Pui-Chung, et al.
Published: (2016)

Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia
by: Aung, Lynn Htet Htet, et al.
Published: (2014)

Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes
by: Kumaraswamy, Sunil B, et al.
Published: (2012)

Influence of acid-base imbalance and hyperlipidaemia on statin-induced myotoxicity
by: Taha, Dhiaa A.
Published: (2017)

Are patients undergoing treatment of hyperlipidaemia with statins the best candidates for early cardiac rehabilitation?
by: Celiński, Rafał, et al.
Published: (2011)

Whole blood viscosity assessment issues V: Prevalence in hypercreatinaemia, hyperglycaemia and hyperlipidaemia
by: Nwose, Ezekiel Uba
Published: (2010)

EFFECT OF HYPERLIPIDAEMIA ON REPRODUCTIVE ORGANS IN MALE ALBINO RABBITS : A HISTOLOGICAL APPROACH
by: Purohit, Ashok, et al.
Published: (2004)

PA01.10. Efficacy of abhyanga and udvartana in sthaulya w s r to hyperlipidaemia
by: Patil, Varsharani, et al.
Published: (2012)

Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis
by: Soehnlein, Oliver, et al.
Published: (2009)

Global and hepatocyte-specific ablation of Bmal1 induces hyperlipidaemia and enhances atherosclerosis
by: Pan, Xiaoyue, et al.
Published: (2016)

Association of the variants and haplotypes in the DOCK7, PCSK9 and GALNT2 genes and the risk of hyperlipidaemia
by: Guo, Tao, et al.
Published: (2015)

Effects of simvastatin on apolipoprotein M in vivo and in vitro
by: Zhang, Xiaoying, et al.
Published: (2011)

The Association Between Apolipoprotein E and Functional Outcome After Traumatic Brain Injury: A Meta-Analysis
by: Li, Lizhuo, et al.
Published: (2015)

Plasma Apolipoproteins and Lipids in Normal Persons and Patients with Hypertension
by: Lee, Seung Sei, et al.
Published: (1986)

Intralipid Decreases Apolipoprotein M Levels and Insulin Sensitivity in Rats
by: Zheng, Lu, et al.
Published: (2014)

Rosiglitazone Enhances Apolipoprotein M (Apom) Expression in Rat's Liver
by: Luo, Guanghua, et al.
Published: (2014)

Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus
by: Wenhan Du, et al.
Published: (2017-05-01)

Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children
by: Hanh, Nguyen Thi Hong, et al.
Published: (2016)

The Apolipoprotein E Polymorphism rs7412 Associates with Body Fatness Independently of Plasma Lipids in Middle Aged Men
by: Tejedor, M. Teresa, et al.
Published: (2014)

Decreased Splenic CD4+ T-Lymphocytes in Apolipoprotein M Gene Deficient Mice
by: Wang, Zhigang, et al.
Published: (2015)

Decreased Activities of Apolipoprotein M Promoter Are Associated with the Susceptibility to Coronary Artery Diseases
by: Zheng, Lu, et al.
Published: (2014)

Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway
by: Jiang, Bo, et al.
Published: (2015)

Apolipoprotein M - a new biomarker in sepsis
by: Christoffersen, Christina, et al.
Published: (2012)

Correlation between Apolipoprotein B/Apolipoprotein A-I Ratio with Atherogenic Index of Plasma among Acute Myocardial Infarction Patients
by: Winardi Emmanuel Setiawan, et al.
Published: (2018-08-01)

The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
by: Kaneva, Anastasiya M., et al.
Published: (2015)

Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice
by: Wang, Xuemei, et al.
Published: (2016)

Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice
by: Nojiri, Takahiro, et al.
Published: (2014)

Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
by: Wolf, Andrew B, et al.
Published: (2013)

Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity
by: Taha, Dhiaa A., et al.
Published: (2017)

Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings
by: Chua, S.S., et al.
Published: (2012)

Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings
by: Chua, Siew Siang, et al.
Published: (2012)